CLR457 T30989
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
CLR457 is an oral bioavailable phosphatidylinositol 3-kinase (PI3K) pan inhibitor with potential anti-tumor activity. CLR457 inhibits all PI3K kinase subtypes, which may inhibit the growth or even apoptosis of tumor cells that overexpress PI3K.
CAS nr:
T30989
Purity:
98%
Molecular Weight:
SMILES:
Unknown
Formula:
Pathway:
Target:
